Lincoln Pharmaceuticals Ltd.
BSE: 531633 | Sector: Health care |
NSE: LINCOLN | ISIN Code: INE405C01035 |
BSE 00:00 | 19 Aug | 292.20 |
-0.95 (-0.32%) |
OPEN
292.80 |
HIGH
293.50 |
LOW
285.05 |
NSE 00:00 | 19 Aug | 292.55 |
-0.80 (-0.27%) |
OPEN
293.35 |
HIGH
294.70 |
LOW
285.35 |
OPEN | 292.80 |
PREVIOUS CLOSE | 293.15 |
VOLUME | 3693 |
52-Week high | 414.75 |
52-Week low | 255.00 |
P/E | 8.78 |
Mkt Cap.(Rs cr) | 585 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Lincoln Pharmaceuticals Ltd. (LINCOLN) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 900.30 | -1.69 | 966.90 | 733.95 | 216008.97 |
Divi's Lab. | 3696.05 | -1.29 | 5425.00 | 3365.10 | 98111.65 |
Cipla | 1030.35 | -0.17 | 1083.15 | 850.00 | 83149.24 |
Dr Reddy's Labs | 4199.95 | -0.61 | 5078.80 | 3655.00 | 69903.97 |
Apollo Hospitals | 4136.85 | -3.13 | 5930.70 | 3365.90 | 59479.63 |
Torrent Pharma. | 1541.85 | -1.18 | 1652.23 | 1242.50 | 52182.37 |
Piramal Enterp. | 1944.55 | -0.90 | 3013.00 | 1561.00 | 46406.69 |
Abbott India | 18845.75 | -0.87 | 23902.30 | 15525.00 | 40047.22 |
Gland Pharma | 2411.90 | 0.53 | 4177.95 | 2180.10 | 39723.99 |
Zydus Lifesci. | 387.65 | -1.64 | 576.25 | 319.40 | 39683.73 |
Biocon | 308.15 | -2.17 | 410.50 | 305.00 | 36996.49 |
Max Healthcare | 378.45 | -1.88 | 472.60 | 312.40 | 36695.65 |
Alkem Lab | 2937.90 | 0.35 | 4067.70 | 2835.00 | 35122.59 |
Aurobindo Pharma | 569.40 | -2.32 | 767.45 | 503.40 | 33361.15 |
Lupin | 689.00 | 0.07 | 995.00 | 583.05 | 31325.39 |
Laurus Labs | 581.80 | -1.43 | 695.70 | 433.20 | 31263.02 |
Glaxosmi. Pharma | 1473.40 | -0.35 | 1917.00 | 1372.80 | 24960.87 |
Syngene Intl. | 584.00 | -2.03 | 686.00 | 508.10 | 23443.51 |
Ipca Labs. | 919.00 | -0.65 | 1383.55 | 831.40 | 23315.03 |
Fortis Health. | 299.15 | 2.61 | 313.80 | 219.80 | 22584.63 |
Quick Links for Lincoln Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices